Studies have shown that active fund managers routinely underperform the S&P500 index*​

BioCardia, Inc. (NASDAQ: BCDA)

BCDA Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%

BCDA Stock Analysis

BCDA PE Ratio:

BCDA PEG Ratio: Not Available

BCDA Forward EPS Growth (12 month): 0.00%

BCDA PS Ratio:

BCDA PSG Ratio: Not Available

BCDA Forward Revenue Growth (12 month): 0.00%

BCDA Articles

No data was found